These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5806836)

  • 21. [On hematopoietic changesin patients with malignant ovarian tumors during chemotherapy].
    Turbina IL; Mezentseva SK
    Vopr Onkol; 1965; 11(8):38-41. PubMed ID: 4957708
    [No Abstract]   [Full Text] [Related]  

  • 22. Intermittent high-dose cyclophosphamide (NSC-26271) treatment of stage III ovarian carcinoma.
    Buckner CD; Briggs R; Clift RA; Fefer A; Funk DD; Glucksberg H; Neiman PE; Storb R; Thomas ED
    Cancer Chemother Rep; 1974; 58(5 Pt 1):697-703. PubMed ID: 4426048
    [No Abstract]   [Full Text] [Related]  

  • 23. [A patient with ovarian cancer metastasis cured (?) by cytostatic agents and died from acute myeloid leukemia].
    Sypkens Smit CG; Meyler L
    Ned Tijdschr Geneeskd; 1970 Sep; 114(39):1620-3. PubMed ID: 4990178
    [No Abstract]   [Full Text] [Related]  

  • 24. [Present state and perspectives concerning the medical treatment of cancer].
    Vermel' EM
    Vopr Onkol; 1969; 15(1):92-104. PubMed ID: 4185056
    [No Abstract]   [Full Text] [Related]  

  • 25. [Phase III study of cisplatin on gynecological malignancy].
    Chen JT; Takizawa K; Kawana T; Kawagoe K; Yoshida R; Yoshikawa H; Mizuno M; Sakamoto S
    Nihon Gan Chiryo Gakkai Shi; 1982 Apr; 17(3):710-9. PubMed ID: 6182259
    [No Abstract]   [Full Text] [Related]  

  • 26. The use of lenograstim (Granocyte) in chemotherapy for ovarian cancer.
    Roongpisuthipong A; Suphanit I; Luamprapat A; Senapad S
    Asian Pac J Allergy Immunol; 1998 Mar; 16(1):43-7. PubMed ID: 9681128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cyclophosphamide--attack dose or continuous therapy].
    Müller U
    Zentralbl Gynakol; 1971 Oct; 93(40):1369-75. PubMed ID: 5126440
    [No Abstract]   [Full Text] [Related]  

  • 28. A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma.
    de Vries EG; Biesma B; Willemse PH; Mulder NH; Stern AC; Aalders JG; Vellenga E
    Cancer Res; 1991 Jan; 51(1):116-22. PubMed ID: 1988077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of cytotoxic chemotherapy in conjunction with gynaecological surgery.
    Guthrie D
    Clin Obstet Gynaecol; 1978 Dec; 5(3):709-27. PubMed ID: 367674
    [No Abstract]   [Full Text] [Related]  

  • 30. [Administration of phytohemagglutinin with cytostatic therapy].
    Eggerth G; Kühböck J; Pokorny D
    Wien Z Inn Med; 1969; 50(12):587-92. PubMed ID: 5385163
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro sensitivity testing of cells of histologically typified ovarian carcinomas and carcinoma of corpus with 3H-cyclophosphamide-metabolites in the serum of man after massive dose therapy.
    Wetzel V; Schaumlöffel E; Jankowski RP
    Int J Clin Pharmacol Biopharm; 1978 Dec; 16(12):600-6. PubMed ID: 730427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-FU infusion and cyclophosphamide in the treatment of advanced ovarian cancer.
    Izbicki RM; Baker LH; Samson MK; McDonald B; Vaitkevicius VK
    Cancer Treat Rep; 1977 Nov; 61(8):1573-5. PubMed ID: 922760
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapeutic trial of a combination of cytostatic agents in advanced ovarian carcinoma].
    Brandl K
    Zentralbl Gynakol; 1970 Feb; 92(8):233-9. PubMed ID: 5505972
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of 126 cases of advanced ovarian carcinoma with cyclophosphamide.
    Beck RE; Boyes DA
    Can Med Assoc J; 1968 Mar; 98(11):539-41. PubMed ID: 5647240
    [No Abstract]   [Full Text] [Related]  

  • 35. [Endoxan in ovarian cancer].
    Campodónico I; Soldati A; Rodríguez A
    Rev Chil Obstet Ginecol; 1974; 39(3):87-9. PubMed ID: 4620179
    [No Abstract]   [Full Text] [Related]  

  • 36. [The modification of hemopoietic system of the white rat by N-mustard-cyclophosphamide ester (Endoxan-Asta)].
    Hambsch K; Otto W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(2):174-89. PubMed ID: 4167554
    [No Abstract]   [Full Text] [Related]  

  • 37. [The tumor cured, but what about the patient?].
    Könczöl F; Farkas N
    Orv Hetil; 2013 Mar; 154(13):510-5. PubMed ID: 23524235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Results of very high cyclophosphamide dosage in 42 patients with solid and lymphoreticular tumors].
    Schubert JC; Ischer M; Hilbert L
    Dtsch Med Wochenschr; 1969 Dec; 94(50):2583-8 passim. PubMed ID: 4187888
    [No Abstract]   [Full Text] [Related]  

  • 39. A controlled clinical trial with the cytostatic agent thyminalkylamine and its fluorinated derivative on advanced ovarian tumours.
    Dvorák O; Elis J; Perlík F; Kvícalová M; Jandová A; Skoda V; Kafka V
    Neoplasma; 1971; 18(4):365-9. PubMed ID: 5568931
    [No Abstract]   [Full Text] [Related]  

  • 40. [Possibilities of drug therapy of gynecologic malignancies].
    Armborst V
    Med Welt; 1967 Oct; 42():2498-501. PubMed ID: 4306391
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.